Contact Us
TEL: +86-0571-88334626
E-mail: sales@tacon-china.com.cn
Home > News > Content
Development Status Of Biotechnology Major
Jun 02, 2018

Biotechnology is one of the fastest developing high technologies in the world. Recombinant DNA technology and hybridoma technology were invented in the 1970s. Cell is established in the 80 s large-scale cultivation of transgenic technology, modern biological technology (genetic engineering) pharmaceutical began in the early eighty s, especially the invention of the PCR technology, make the development of modern biological technology by leaps and bounds, in the 90 s, with the human genome project and the implementation of the important crops and microbial genome project and the infiltration of information technology, the successive development of functional genomics and bioinformatics, and combinatorial chemistry, biological chip technology and a series of automated analysis and drug screening technology and equipment. Various emerging biotechnology has been widely used in medical treatment, agriculture, biological processing, resource exploitation and utilization, environmental protection, and has had a profound impact on the development of pharmaceutical and other industries.

The development of biotechnology has gone through two stages of the development of traditional biotechnology and modern biotechnology, fermentation engineering, in which genetic engineering is the core technology. Because of biological technology to solve the problem of human face will be major issues such as food, health, environment, energy, open up broad prospects, it microelectronics and computer technology, new material, new energy, space technology, etc are classified as high-tech, is considered to be the core of science and technology in the 21st century. At present, the most active application field of biotechnology is the biomedical industry, and biopharmaceuticals (often referred to as gene recombinant drugs) are regarded by investors as one of the industries with the highest growth. Major pharmaceutical companies all over the world have targeted their targets, invested huge sums of money to develop biological drugs, and launched unprecedented fierce competition for the 21st century.